Symbols / SVRA Stock $4.93 -4.09% Savara Inc.

Healthcare • Biotechnology • United States • NMS
SVRA (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Langhorne, Pennsylvania.

Stock Fundamentals
Scroll to Statements
Market Cap 1.01B Enterprise Value 1.10B Income -118.84M Sales — Book/sh 0.80 Cash/sh 0.93
Dividend Yield — Payout 0.00% Employees 70 IPO — P/E — Forward P/E -15.12
PEG — P/S — P/B 6.15 P/C — EV/EBITDA -8.93 EV/Sales —
Quick Ratio 11.66 Current Ratio 11.85 Debt/Eq 14.73 LT Debt/Eq — EPS (ttm) -0.53 EPS next Y -0.33
EPS Growth — Revenue Growth — Earnings 2026-05-13 ROA -32.91% ROE -63.45% ROIC —
Gross Margin 0.00% Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 204.66M Shs Float 130.03M Short Float 15.60%
Short Ratio 15.04 Short Interest — 52W High 7.00 52W Low 1.89 Beta 0.31 Avg Volume 1.60M
Volume 1.36M Target Price $10.56 Recom Strong_buy Prev Close $5.14 Price $4.93 Change -4.09%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$10.56
Mean price target
2. Current target
$4.93
Latest analyst target
3. DCF / Fair value
$-4.88
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$4.93
Low
$9.00
High
$16.00
Mean
$10.56

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-12-23 main HC Wainwright & Co. Buy → Buy $10
2025-12-18 main Wells Fargo Overweight → Overweight $9
2025-11-14 main Oppenheimer Outperform → Outperform $9
2025-11-13 main Citizens Market Outperform → Market Outperform $10
2025-10-23 main JMP Securities Market Outperform → Market Outperform $11
2025-09-09 main Guggenheim Buy → Buy $11
2025-09-08 main Oppenheimer Outperform → Outperform $8
2025-09-03 main HC Wainwright & Co. Buy → Buy $8
2025-08-15 main Oppenheimer Outperform → Outperform $6
2025-08-15 up HC Wainwright & Co. Neutral → Buy $5
2025-06-01 main Oppenheimer Outperform → Outperform $5
2025-05-29 down HC Wainwright & Co. Buy → Neutral $2
2025-05-28 main Evercore ISI Group In-Line → In-Line $2
2025-05-28 main Guggenheim Buy → Buy $8
2025-05-28 main Wells Fargo Overweight → Overweight $7
2025-03-31 main Evercore ISI Group In-Line → Hold $3
2025-03-28 reit HC Wainwright & Co. Buy → Buy $6
2024-12-20 init Wells Fargo — → Overweight $8
2024-12-19 reit JMP Securities Market Outperform → Market Outperform $9
2024-11-13 main HC Wainwright & Co. Buy → Buy $6
News
RSS: Latest SVRA news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-18 LOWRANCE DAVID L. CPA Chief Financial Officer — 366,747 $1.11 $588,455
2026-02-13 MCCRACKEN JOSEPH S Director — 1,807 $1.76 $3,180
2025-12-16 LOWRANCE DAVID L. CPA Chief Financial Officer — 32,000 $0.00 $0
2025-12-16 PAULS MATTHEW Chief Executive Officer — 128,995 $0.00 $0
2025-12-10 PAULS MATTHEW Chief Executive Officer — 23,629 $0.00 $0
2025-12-09 VAN ES-JOHANSSON AN Director — 40,000 $0.00 $0
2025-12-09 HAWKINS RICHARD JAMES Director — 40,000 $0.00 $0
2025-12-09 ELAM NEVAN C Director — 40,000 $0.00 $0
2025-12-09 MCCRACKEN JOSEPH S Director — 40,000 $0.00 $0
2025-12-02 ELAM NEVAN C Director — 5,860 $1.46 $8,556
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
122.76
+19.89%
102.40
+72.94%
59.21
+55.64%
38.04
Research And Development
81.40
+4.33%
78.03
+76.29%
44.26
+58.76%
27.88
Selling General And Administration
42.06
+67.98%
25.04
+59.80%
15.67
+43.36%
10.93
General And Administrative Expense
42.06
+67.98%
25.04
+59.80%
15.67
+43.36%
10.93
Other Gand A
42.06
+67.98%
25.04
+59.80%
15.67
+43.36%
10.93
Total Expenses
122.76
+19.89%
102.40
+72.94%
59.21
+55.64%
38.04
Operating Income
-122.76
-19.89%
-102.40
-72.94%
-59.21
-55.64%
-38.04
Total Operating Income As Reported
-123.55
-19.72%
-103.20
-71.97%
-60.01
-54.50%
-38.84
EBITDA
-122.68
-19.95%
-102.27
-72.95%
-59.13
-56.12%
-37.88
Normalized EBITDA
-122.44
-19.66%
-102.32
-72.81%
-59.21
-56.40%
-37.86
Reconciled Depreciation
0.09
-33.08%
0.13
+68.83%
0.08
-53.89%
0.17
EBIT
-122.76
-19.89%
-102.40
-72.94%
-59.21
-55.64%
-38.04
Total Unusual Items
-0.24
-562.75%
0.05
-32.89%
0.08
+500.00%
-0.02
Total Unusual Items Excluding Goodwill
-0.24
-562.75%
0.05
-32.89%
0.08
+500.00%
-0.02
Special Income Charges
-0.55
0.00
—
—
Other Special Charges
0.55
—
—
—
Net Income
-118.84
-23.94%
-95.88
-75.29%
-54.70
-43.38%
-38.15
Pretax Income
-118.84
-23.94%
-95.88
-75.29%
-54.70
-43.38%
-38.15
Net Non Operating Interest Income Expense
4.16
-35.64%
6.47
+45.78%
4.44
+5140.91%
-0.09
Interest Expense Non Operating
—
—
—
0.09
Net Interest Income
4.16
-35.64%
6.47
+45.78%
4.44
+5140.91%
-0.09
Interest Expense
—
—
—
0.09
Interest Income Non Operating
4.16
-35.64%
6.47
+45.78%
4.44
—
Interest Income
4.16
-35.64%
6.47
+45.78%
4.44
—
Other Income Expense
-0.24
-562.75%
0.05
-32.89%
0.08
+500.00%
-0.02
Gain On Sale Of Security
0.31
+507.84%
0.05
-32.89%
0.08
+500.00%
-0.02
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-118.84
-23.94%
-95.88
-75.29%
-54.70
-43.38%
-38.15
Net Income From Continuing Operation Net Minority Interest
-118.84
-23.94%
-95.88
-75.29%
-54.70
-43.38%
-38.15
Net Income From Continuing And Discontinued Operation
-118.84
-23.94%
-95.88
-75.29%
-54.70
-43.38%
-38.15
Net Income Continuous Operations
-118.84
-23.94%
-95.88
-75.29%
-54.70
-43.38%
-38.15
Normalized Income
-118.60
-23.63%
-95.93
-75.14%
-54.77
-43.65%
-38.13
Net Income Common Stockholders
-118.84
-23.94%
-95.88
-75.29%
-54.70
-43.38%
-38.15
Diluted EPS
-0.53
-10.42%
-0.48
-45.45%
-0.33
-32.00%
-0.25
Basic EPS
-0.53
-10.42%
-0.48
-45.45%
-0.33
-32.00%
-0.25
Basic Average Shares
222.39
+12.21%
198.19
+19.97%
165.20
+8.14%
152.77
Diluted Average Shares
222.39
+12.21%
198.19
+19.97%
165.20
+8.14%
152.77
Diluted NI Availto Com Stockholders
-118.84
-23.94%
-95.88
-75.29%
-54.70
-43.38%
-38.15
Depreciation Amortization Depletion Income Statement
0.09
-33.08%
0.13
+68.83%
0.08
+148.39%
0.03
Depreciation And Amortization In Income Statement
0.09
-33.08%
0.13
+68.83%
0.08
+148.39%
0.03
Other Taxes
-0.78
+1.63%
-0.80
+0.00%
-0.80
-0.13%
-0.80
Total Other Finance Cost
—
—
-4.44
-5140.91%
0.09
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
253.44
+19.05%
212.88
+19.89%
177.56
+27.03%
139.78
Current Assets
241.62
+19.53%
202.13
+21.81%
165.95
+28.69%
128.95
Cash Cash Equivalents And Short Term Investments
235.70
+20.06%
196.33
+20.95%
162.32
+28.95%
125.88
Cash And Cash Equivalents
33.18
+119.33%
15.13
-43.10%
26.59
-48.97%
52.10
Other Short Term Investments
202.52
+11.77%
181.20
+33.50%
135.73
+83.98%
73.78
Receivables
1.25
+20.23%
1.04
+3.78%
1.00
+5.35%
0.95
Taxes Receivable
1.25
+20.23%
1.04
+3.78%
1.00
+5.35%
0.95
Prepaid Assets
3.37
-21.72%
4.31
+83.95%
2.34
+14.13%
2.05
Hedging Assets Current
0.39
0.00
—
—
Other Current Assets
0.89
+96.04%
0.46
+62.50%
0.28
+294.37%
0.07
Total Non Current Assets
11.82
+10.01%
10.74
-7.51%
11.62
+7.34%
10.82
Net PPE
0.10
-39.39%
0.17
-38.89%
0.27
+429.41%
0.05
Gross PPE
2.43
+4.56%
2.33
+1.97%
2.28
+15.60%
1.97
Accumulated Depreciation
-2.33
-7.91%
-2.16
-7.46%
-2.01
-4.63%
-1.92
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.12
+0.00%
0.12
+9.09%
0.11
+80.33%
0.06
Other Properties
1.98
+5.66%
1.87
+1.90%
1.84
+4.02%
1.77
Leases
0.33
+0.00%
0.33
+0.00%
0.33
+129.66%
0.14
Other Intangible Assets
11.64
+12.57%
10.34
-5.68%
10.96
+2.85%
10.66
Other Non Current Assets
0.08
-65.29%
0.24
-37.47%
0.39
+233.62%
0.12
Total Liabilities Net Minority Interest
50.30
+21.42%
41.43
+11.39%
37.19
+16.23%
32.00
Current Liabilities
20.40
+38.52%
14.72
+38.94%
10.60
+80.62%
5.87
Payables And Accrued Expenses
13.47
+40.50%
9.59
+49.67%
6.41
+86.39%
3.44
Payables
5.76
+26.67%
4.54
+29.71%
3.50
+162.67%
1.33
Accounts Payable
5.76
+26.67%
4.54
+29.71%
3.50
+162.67%
1.33
Current Accrued Expenses
7.72
+52.95%
5.05
+73.76%
2.90
+38.02%
2.10
Pensionand Other Post Retirement Benefit Plans Current
6.55
+30.60%
5.02
+24.00%
4.05
+71.08%
2.37
Current Debt And Capital Lease Obligation
0.01
-93.97%
0.12
-18.88%
0.14
+123.44%
0.06
Current Debt
—
—
—
—
Other Current Borrowings
—
—
—
—
Current Capital Lease Obligation
0.01
-93.97%
0.12
-18.88%
0.14
+123.44%
0.06
Other Current Liabilities
0.36
—
—
—
Total Non Current Liabilities Net Minority Interest
29.91
+11.99%
26.71
+0.42%
26.59
+1.77%
26.13
Long Term Debt And Capital Lease Obligation
29.91
+12.35%
26.62
+1.03%
26.35
+1.04%
26.08
Long Term Debt
29.91
+12.35%
26.62
+1.03%
26.35
+1.04%
26.08
Other Non Current Liabilities
—
0.09
-64.78%
0.25
+357.41%
0.05
Stockholders Equity
203.13
+18.48%
171.45
+22.14%
140.37
+30.24%
107.78
Common Stock Equity
203.13
+18.48%
171.45
+22.14%
140.37
+30.24%
107.78
Capital Stock
0.20
+17.92%
0.17
+23.57%
0.14
+20.69%
0.12
Common Stock
0.20
+17.92%
0.17
+23.57%
0.14
+20.69%
0.12
Share Issued
204.57
+18.64%
172.42
+24.81%
138.14
+21.13%
114.05
Ordinary Shares Number
204.57
+18.64%
172.42
+24.81%
138.14
+21.13%
114.05
Additional Paid In Capital
811.10
+22.66%
661.28
+23.86%
533.87
+19.45%
446.94
Retained Earnings
-608.09
-24.29%
-489.25
-24.37%
-393.37
-16.15%
-338.67
Gains Losses Not Affecting Retained Earnings
-0.09
+88.40%
-0.75
-176.75%
-0.27
+55.21%
-0.60
Other Equity Adjustments
-0.09
+88.40%
-0.75
-176.75%
-0.27
+55.21%
-0.60
Total Equity Gross Minority Interest
203.13
+18.48%
171.45
+22.14%
140.37
+30.24%
107.78
Total Capitalization
233.04
+17.66%
198.07
+18.80%
166.72
+24.55%
133.86
Working Capital
221.22
+18.04%
187.41
+20.64%
155.35
+26.21%
123.09
Invested Capital
233.04
+17.66%
198.07
+18.80%
166.72
+24.55%
133.86
Total Debt
29.91
+11.89%
26.73
+0.92%
26.49
+1.34%
26.14
Net Debt
—
11.49
—
—
Capital Lease Obligations
0.01
-93.97%
0.12
-18.88%
0.14
+123.44%
0.06
Net Tangible Assets
191.50
+18.86%
161.11
+24.50%
129.41
+33.25%
97.12
Tangible Book Value
191.50
+18.86%
161.11
+24.50%
129.41
+33.25%
97.12
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-101.04
-13.41%
-89.09
-74.47%
-51.06
-47.77%
-34.55
Cash Flow From Continuing Operating Activities
-101.04
-13.41%
-89.09
-74.47%
-51.06
-47.77%
-34.55
Net Income From Continuing Operations
-118.84
-23.94%
-95.88
-75.29%
-54.70
-43.38%
-38.15
Depreciation Amortization Depletion
0.09
-33.08%
0.13
+68.83%
0.08
-53.89%
0.17
Depreciation
—
—
0.17
+4.79%
0.17
Depreciation And Amortization
0.09
-33.08%
0.13
+68.83%
0.08
-53.89%
0.17
Other Non Cash Items
0.45
+67.16%
0.27
+0.00%
0.27
-18.86%
0.33
Stock Based Compensation
14.42
+46.26%
9.86
+136.00%
4.18
+104.70%
2.04
Operating Gains Losses
0.70
+385.52%
0.14
+559.09%
0.02
+15.79%
0.02
Unrealized Gain Loss On Investment Securities
—
—
—
—
Net Foreign Currency Exchange Gain Loss
—
0.00
+100.00%
-0.08
-500.00%
0.02
Gain Loss On Sale Of PPE
0.16
+8.97%
0.14
+47.96%
0.10
—
Change In Working Capital
5.00
+173.43%
1.83
-55.09%
4.07
+324.27%
0.96
Change In Prepaid Assets
0.10
+104.07%
-2.38
-422.59%
-0.46
-134.13%
1.34
Change In Payables And Accrued Expense
4.81
+14.40%
4.20
-7.49%
4.54
+1523.51%
-0.32
Change In Payable
4.81
+14.40%
4.20
-7.49%
4.54
+1523.51%
-0.32
Change In Account Payable
4.81
+14.40%
4.20
-7.49%
4.54
+1523.51%
-0.32
Change In Other Current Assets
0.10
+790.91%
0.01
+191.67%
-0.01
+78.95%
-0.06
Change In Other Current Liabilities
—
—
—
0.00
Investing Cash Flow
-18.44
+53.83%
-39.94
+30.07%
-57.12
-208.49%
52.65
Cash Flow From Continuing Investing Activities
-18.44
+53.83%
-39.94
+30.07%
-57.12
-208.49%
52.65
Net PPE Purchase And Sale
-0.02
+12.00%
-0.03
+91.55%
-0.30
-3188.89%
-0.01
Purchase Of PPE
-0.02
+12.00%
-0.03
+91.55%
-0.30
-3188.89%
-0.01
Capital Expenditure
-0.02
+12.00%
-0.03
+91.55%
-0.30
-3188.89%
-0.01
Net Investment Purchase And Sale
-18.42
+53.86%
-39.92
+29.75%
-56.82
-207.91%
52.65
Purchase Of Investment
-204.90
+0.01%
-204.92
-5.51%
-194.22
-117.21%
-89.42
Sale Of Investment
186.48
+13.02%
165.00
+20.09%
137.40
-3.29%
142.07
Net Intangibles Purchase And Sale
—
—
—
—
Purchase Of Intangibles
—
—
—
—
Financing Cash Flow
137.81
+17.20%
117.58
+42.04%
82.78
+95049.43%
0.09
Cash Flow From Continuing Financing Activities
137.81
+17.20%
117.58
+42.04%
82.78
+95049.43%
0.09
Net Issuance Payments Of Debt
2.37
0.00
0.00
-100.00%
0.09
Issuance Of Debt
29.60
0.00
0.00
-100.00%
26.44
Repayment Of Debt
-27.23
0.00
0.00
+100.00%
-26.35
Long Term Debt Issuance
29.60
0.00
0.00
-100.00%
26.44
Long Term Debt Payments
-27.23
0.00
0.00
+100.00%
-26.35
Net Long Term Debt Issuance
2.37
0.00
0.00
-100.00%
0.09
Net Common Stock Issuance
135.09
+15.29%
117.18
+42.04%
82.50
+2750000.00%
-0.00
Common Stock Payments
-5.14
-416.58%
-0.99
+17.63%
-1.21
-40166.67%
-0.00
Repurchase Of Capital Stock
-5.14
-416.58%
-0.99
+17.63%
-1.21
-40166.67%
-0.00
Proceeds From Stock Option Exercised
0.35
-1.41%
0.35
+25.09%
0.28
+14050.00%
0.00
Net Other Financing Charges
—
0.05
—
—
Changes In Cash
18.33
+260.05%
-11.45
+54.91%
-25.40
-239.71%
18.18
Effect Of Exchange Rate Changes
-0.28
-5440.00%
-0.01
+95.76%
-0.12
-31.11%
-0.09
Beginning Cash Position
15.13
-43.10%
26.59
-48.97%
52.10
+53.18%
34.01
End Cash Position
33.18
+119.33%
15.13
-43.10%
26.59
-48.97%
52.10
Free Cash Flow
-101.06
-13.41%
-89.11
-73.52%
-51.36
-48.59%
-34.56
Interest Paid Supplemental Data
3.20
+50.71%
2.12
+4.12%
2.04
+26.39%
1.61
Amortization Of Securities
-2.87
+47.34%
-5.44
-9.19%
-4.98
-6745.33%
0.07
Common Stock Issuance
140.23
+18.66%
118.17
+41.18%
83.70
0.00
Issuance Of Capital Stock
140.23
+18.66%
118.17
+41.18%
83.70
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category